CYTOCHROMA

cytochroma-logo

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

#People #Financial #Website #More

CYTOCHROMA

Industry:
Biotechnology Clinical Trials Pharmaceutical

Founded:
1996-01-01

Address:
Kingston, Ontario, Canada

Country:
Canada

Website Url:
http://www.cytochroma.com

Total Employee:
51+

Status:
Closed

Contact:
847-236-7707

Total Funding:
75.83 M USD

Technology used in webpage:
SPF Amazon GoDaddy DNS AWS Global Accelerator AppRiver



Current Advisors List

seiichi-kiso_image

Seiichi Kiso Board of Director @ Cytochroma
Board_member
2008-07-30

joseph-regan_image

Joseph Regan Member of the Board of Directors @ Cytochroma
Board_member
2004-01-01

Acquisitions List

Date Company Article Price
2006-06-29 Proventiv Therapeutics Proventiv Therapeutics acquired by Cytochroma N/A

Investors List

caisse-de-depot-et-placement-du-quebec_image

Caisse de Depot et Placement du Quebec

Caisse de Depot et Placement du Quebec investment in Series C - Cytochroma

canadian-medical-discoveries-fund_image

Canadian Medical Discoveries Fund

Canadian Medical Discoveries Fund investment in Series C - Cytochroma

mitsubishi-tanabe-pharma_image

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma investment in Series C - Cytochroma

venturelink-lp_image

VentureLink LP

VentureLink LP investment in Series C - Cytochroma

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Cytochroma

vengrowth-asset-management_image

VenGrowth Asset Management

VenGrowth Asset Management investment in Series C - Cytochroma

bdc-capital-corporation_image

BDC Capital Corporation

BDC Capital Corporation investment in Series C - Cytochroma

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Series C - Cytochroma

genechem_image

GeneChem

GeneChem investment in Series C - Cytochroma

vengrowth-asset-management_image

VenGrowth Asset Management

VenGrowth Asset Management investment in Series C - Cytochroma

Official Site Inspections

http://www.cytochroma.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 3.33.251.168
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Cytochroma" on Search Engine